L&G Healthcare Technology & Innovation ETF USD Acc (DOCG)

Category Sector Equity Healthcare


This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell

1,108.40p

Buy

1,113.00p

arrow-up3.00p (+0.27%)

Prices updated at 12 Dec 2025, 16:21 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The investment objective of the Fund is to provide exposure to the global healthcare technology industry. In order to achieve this investment objective, the Fund will seek to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.

arrow-down-0.48%
LSE

Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.

Portfolio as of 11/12/2025

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Stock style

Small core

22.08%

% Weight
Value
Core
Growth
Large

7

13

3

Medium

1

15

17

Small

3

22

17

Valuation

L&G Healthcare Technology & Innovation ETF USD Acc
Sector Equity Healthcare

21.71

21.71
18.97

1.96

1.96
1.92

3.70

3.70
4.17

14.37

14.37
13.61

Growth rate

L&G Healthcare Technology & Innovation ETF USD Acc
Sector Equity Healthcare

6.63%

6.63%
9.32%

0.43%

0.43%
1.51%

-2.71%

-2.71%
4.08%

Top 10 holdings

1
Arrowhead Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.99609
2
Axogen Inc
Sector
-
Country
United States
% of assets
3.20614
3
Guardant Health Inc
Sector
-
Country
United States
% of assets
2.88129
4
GRAIL Inc
Sector
-
Country
United States
% of assets
2.81684
5
Exact Sciences Corp
Sector
-
Country
United States
% of assets
2.76839
6
Natera Inc
Sector
-
Country
United States
% of assets
2.35008
7
Illumina Inc
Sector
-
Country
United States
% of assets
2.16836
8
Regeneron Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
2.04792
9
Thermo Fisher Scientific Inc
Sector
-
Country
United States
% of assets
2.00848
10
Intuitive Surgical Inc
Sector
-
Country
United States
% of assets
2.00371
Assets in top 10 holdings %

26.25%

Total no. of equity holdings

62.00

Total no. of bond holdings

-

Stock sectors

L&G Healthcare Technology & Innovation ETF USD Acc
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

1.46%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

1.46%
-

98.54%

Con defensive

-
-

Healthcare

98.54%
-

Utilities

-
-


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.